Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cartesian Therapeutics (RNAC) Return on Invested Capital: 2022

  • Cartesian Therapeutics' Return on Invested Capital was N/A to 0.04% in Q4 2022 from the same period last year, while for Dec 2022 it was 0.04%, marking a year-over-year change of. This contributed to the annual value of 0.51% for FY2023, which is N/A change from last year.
  • Per Cartesian Therapeutics' latest filing, its Return on Invested Capital stood at 0.04% for Q4 2022.
  • In the past 5 years, Cartesian Therapeutics' Return on Invested Capital registered a high of 0.04% during Q4 2022, and its lowest value of 0.04% during Q4 2022.
  • For the 1-year period, Cartesian Therapeutics' Return on Invested Capital averaged around 0.04%, with its median value being 0.04% (2022).